
ANTH
Healthcare · Biotechnology · $2,617 market cap
$0.00010.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2018
EPS trend, 90 days to now · 30-day revisions 1 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 18, 2024 | Time not confirmed | — | 0.00 | — |
| Aug 7, 2024 | Time not confirmed | — | 0.00 | — |
| May 9, 2024 | Time not confirmed | — | 0.00 | — |
| Mar 5, 2024 | Time not confirmed | — | 0.00 | — |
| Nov 6, 2023 | Time not confirmed | — | 0.00 | — |
| Aug 9, 2023 | Time not confirmed | — | 0.00 | — |
| May 11, 2023 | Time not confirmed | — | 0.00 | — |
| Mar 7, 2023 | Time not confirmed | — | 0.00 | — |
| Nov 7, 2022 | Time not confirmed | — | 0.00 | — |
| Aug 10, 2022 | Time not confirmed | — | 0.00 | — |
| May 12, 2022 | Time not confirmed | — | 0.00 | — |
| Mar 8, 2022 | Time not confirmed | — | 0.00 | — |
| Nov 8, 2021 | Time not confirmed | — | 0.00 | — |
| Aug 11, 2021 |
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the…
| Time not confirmed |
| — |
| 0.00 |
| — |
| May 13, 2021 | Time not confirmed | — | 0.00 | — |
| Mar 9, 2021 | Time not confirmed | — | 0.00 | — |
| Nov 2, 2020 | Time not confirmed | — | 0.00 | — |
| Aug 12, 2020 | Time not confirmed | — | 0.00 | — |
| May 14, 2020 | Time not confirmed | — | 0.00 | — |
| Mar 4, 2020 | Time not confirmed | -0.03 | 0.00 | +100.0% |
| Nov 11, 2019 | Time not confirmed | -0.03 | 0.00 | +100.0% |
| Aug 5, 2019 | Time not confirmed | -0.03 | 0.00 | +100.0% |
| May 20, 2019 | Time not confirmed | -0.02 | 0.00 | +100.0% |
| Mar 6, 2019 | Time not confirmed | -0.72 | 0.00 | +100.0% |
| Nov 7, 2018 | Time not confirmed | -0.45 | 0.00 | +100.0% |
| Jul 31, 2018 | Time not confirmed | -0.46 | 0.00 | +100.0% |
| May 15, 2018 | After the close | -0.53 | -0.42 | +20.8% |
| Mar 5, 2018 | After the close | -0.66 | -0.73 | -10.6% |